Cargando…
The compound AST-003 could effectively promote apoptosis of renal cell carcinoma cells in vitro
BACKGROUND: The toxicity of Sunitinib limits its clinical application. A new compound AST-003 was designed and synthesized based on the structure of Sunitinib, and previous study has confirmed that AST-003 has the same efficacy and less toxicity as Sunitinib. We conducted this study to further verif...
Autores principales: | Tang, Xingxing, Zhao, Qiang, Liu, Jia, Wang, Shuo, Zhang, Ning, Yang, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798530/ https://www.ncbi.nlm.nih.gov/pubmed/35116532 http://dx.doi.org/10.21037/tcr-20-3330 |
Ejemplares similares
-
Prodrug AST-003 Improves the Therapeutic Index of the Multi-Targeted Tyrosine Kinase Inhibitor Sunitinib
por: Huang, Qiang, et al.
Publicado: (2015) -
AB003. Management of small renal masses
por: Greene, Kirsten L.
Publicado: (2018) -
Angular analysis of $ {B}^0\to {D}^{\ast -}{D}_s^{\ast +} $ with $ {D}_s^{\ast +}\to {D}_s^{+}\gamma $ decays
por: Aaij, Roel, et al.
Publicado: (2021) -
Test of HQET with B^\ast, B^\ast \ast and lifetime measurements of B_s mesons and beauty baryons at DELPHI
por: Siccama, I
Publicado: (1995) -
Deciphering targeting rules of splicing modulator compounds: case of TG003
por: Sakuma, Maki, et al.
Publicado: (2015)